Mechanisms of Drug Resistance in Mycobacterium tuberculosis
Open accessThe DOI matches its Crossref record; 269 of the 269 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Self-citationThe Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., & Dye, C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1009 · Cited by 2,553
Brennan, P. J., & Nikaido, H. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.000333 · Cited by 1,985
Molecular mechanisms that confer antibacterial drug resistance
Walsh, C. (2000) · Nature · doi:10.1038/35021219 · Cited by 1,578
Wang, J. C. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.003313 · Cited by 1,540
inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389
Tuberculosis: Commentary on a Reemergent Killer
Bloom, B. R., & Murray, C. J. L. (1992) · Science · doi:10.1126/science.257.5073.1055 · Cited by 1,373
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
Telenti, A., Imboden, P., Marchesi, F., Matter, L., Schopfer, K., Bodmer, T., Lowrie, D., Colston, M. J., & Cole, S. (1993) · The Lancet · doi:10.1016/0140-6736(93)90417-f · Cited by 1,337
Self-citationAn Enzyme from Bacteria able to Destroy Penicillin
ABRAHAM, E. P., & CHAIN, E. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,333
Sturgill-Koszycki, S., Schlesinger, P. H., Chakraborty, P., Haddix, P. L., Collins, H. L., Fok, A. K., Allen, R. D., Gluck, S. L., Heuser, J., & Russell, D. G. (1994) · Science · doi:10.1126/science.8303277 · Cited by 1,302
The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S. (1992) · Nature · doi:10.1038/358591a0 · Cited by 1,299
Self-citationBass, J. B., Farer, L. S., Hopewell, P. C., O'Brien, R., Jacobs, R. F., Ruben, F., Snider, D. E., & Thornton, G. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.5.8173779 · Cited by 1,193
Interaction of antibiotics with functional sites in 16S ribosomal RNA
Moazed, D., & Noller, H. F. (1987) · Nature · doi:10.1038/327389a0 · Cited by 1,150
Sreevatsan, S., Pan, X., Stockbauer, K. E., Connell, N. D., Kreiswirth, B. N., Whittam, T. S., & Musser, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9869 · Cited by 1,024
Daley, C. L., Small, P. M., Schecter, G. F., Schoolnik, G. K., McAdam, R. A., Jacobs, W. R., & Hopewell, P. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260404 · Cited by 986
The Emergence of Drug-Resistant Tuberculosis in New York City
Frieden, T. R., Sterling, T., Pablos-Mendez, A., Kilburn, J. O., Cauthen, G. M., & Dooley, S. W. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302253280801 · Cited by 939
INFECTIVE HEREDITY OF MULTIPLE DRUG RESISTANCE IN BACTERIA
Watanabe, T. (1963) · Bacteriological Reviews · doi:10.1128/br.27.1.87-115.1963 · Cited by 865
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
Barnes, P. F., Bloch, A. B., Davidson, P. T., & Snider, D. E. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106063242307 · Cited by 862
Edlin, B. R., Tokars, J. I., Grieco, M. H., Crawford, J. T., Williams, J., Sordillo, E. M., Ong, K. R., Kilburn, J. O., Dooley, S. W., Castro, K. G., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206043262302 · Cited by 861
Okusu, H., Ma, D., & Nikaido, H. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.1.306-308.1996 · Cited by 814
Efflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 798
Noller, H. F. (1984) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.53.070184.001003 · Cited by 792
Scorpio, A., & Zhang, Y. (1996) · Nature Medicine · doi:10.1038/nm0696-662 · Cited by 726
The curious characteristics of pyrazinamide: a review.
Zhang, Y., & Mitchison, D. A. (2003) · PubMed · Cited by 723
Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and Rifampin
Goble, M., Iseman, M. D., Madsen, L. A., Waite, D., Ackerson, L., & Horsburgh, C. R. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302253280802 · Cited by 698
Jin, D. J., & Gross, C. A. (1988) · Journal of Molecular Biology · doi:10.1016/0022-2836(88)90517-7 · Cited by 683
Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis
Rozwarski, D. A., Grant, G. A., Barton, D. H. R., Jacobs, W. R., & Sacchettini, J. C. (1998) · Science · doi:10.1126/science.279.5347.98 · Cited by 682
Molecular Koch's Postulates Applied to Microbial Pathogenicity
Falkow, S. (1988) · Clinical Infectious Diseases · doi:10.1093/cid/10.supplement_2.s274 · Cited by 655
Antimicrobial agent resistance in mycobacteria: molecular genetic insights
Musser, J. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.496 · Cited by 621
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., & Nakamura, S. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1271 · Cited by 570
Wilson, M., DeRisi, J., Kristensen, H.-H., Imboden, P., Rane, S., Brown, P. O., & Schoolnik, G. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12833 · Cited by 547
M. tuberculosis persistence, latency, and drug tolerance
Gomez, J. E., & McKinney, J. D. (2004) · Tuberculosis · doi:10.1016/j.tube.2003.08.003 · Cited by 533
Global Incidence of Multidrug‐Resistant Tuberculosis
Zignol, M., Hosseini, M. S., Wright, A., Weezenbeek, C. L., Nunn, P., Watt, C. J., Williams, B. G., & Dye, C. (2006) · The Journal of Infectious Diseases · doi:10.1086/505877 · Cited by 524
The action of antituberculosis drugs in short-course chemotherapy
Mitchison, D. A. (1985) · Tubercle · doi:10.1016/0041-3879(85)90040-6 · Cited by 518
Small, P. M., Shafer, R. W., Hopewell, P. C., Singh, S. P., Murphy, M. J., Desmond, E., Sierra, M. F., & Schoolnik, G. K. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304223281601 · Cited by 512
Espinal, M. A., Kim, S. J., Suarez, P. G., Kam, K. M., Khomenko, A. G., Migliori, G. B., Baéz, J., Kochi, A., Dye, C., & Raviglione, M. C. (2000) · JAMA · doi:10.1001/jama.283.19.2537 · Cited by 507
Takiff, H. E., Salazar, L., Guerrero, C., Philipp, W., Huang, W. M., Kreiswirth, B., Cole, S. T., Jacobs, W. R., & Telenti, A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.773 · Cited by 480
Self-citationZhang, Y. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg446 · Cited by 477
STREPTOMYCIN, SUPPRESSION, AND THE CODE
Davies, J., Gilbert, W., & Gorini, L. (1964) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.51.5.883 · Cited by 474
The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol
Telenti, A., Philipp, W. J., Sreevatsan, S., Bernasconi, C., Stockbauer, K. E., Wieles, B., Musser, J. M., & Jacobs, W. R. (1997) · Nature Medicine · doi:10.1038/nm0597-567 · Cited by 472
Self-citationBelanger, A. E., Besra, G. S., Ford, M. E., Mikusová, K., Belisle, J. T., Brennan, P. J., & Inamine, J. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11919 · Cited by 466
Observations on the Mechanism of Action of Penicillin.
Hobby, G. L., Meyer, K., & Chaffee, E. (1942) · Experimental Biology and Medicine · doi:10.3181/00379727-50-13773 · Cited by 444
Jacobs, W. R., Barletta, R. G., Udani, R., Chan, J., Kalkut, G., Sosne, G., Kieser, T., Sarkis, G. J., Hatfull, G. F., & Bloom, B. R. (1993) · Science · doi:10.1126/science.8484123 · Cited by 439
THE MAGIC BULLETS AND TUBERCULOSIS DRUG TARGETS
Zhang, Y. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.100120 · Cited by 432
Crystal Structure and Function of the Isoniazid Target of Mycobacterium tuberculosis
Dessen, A., Quémard, A., Blanchard, J. S., Jacobs, W. R., & Sacchettini, J. C. (1995) · Science · doi:10.1126/science.7886450 · Cited by 430
Misreading of RNA Codewords Induced by Aminoglycoside Antibiotics
DAVIES, J., GORINI, L., & DAVIS, B. D. (1965) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14722-6 · Cited by 398
Rifampin: Mechanisms of Action and Resistance
Wehrli, W. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.supplement_3.s407 · Cited by 397
Cell Genetics and Hereditary Symbiosis
Lederberg, J. (1952) · Physiological Reviews · doi:10.1152/physrev.1952.32.4.403 · Cited by 387
Snider, D. E., & Roper, W. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203053261011 · Cited by 382
Bifani, P. J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530300036037 · Cited by 381
The resurgence of tuberculosis: is your laboratory ready?
Tenover, F. C., Crawford, J. T., Huebner, R. E., Geiter, L. J., Horsburgh, C. R., & Good, R. C. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.4.767-770.1993 · Cited by 374
Hazbón, M. H., Brimacombe, M., Bobadilla del Valle, M., Cavatore, M., Guerrero, M. I., Varma-Basil, M., Billman-Jacobe, H., Lavender, C., Fyfe, J., García-García, L., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00112-06 · Cited by 374
Enzymic Characterization of the Target for Isoniazid in Mycobacterium tuberculosis
Quemard, A., Sacchettini, J. C., Dessen, A., Vilcheze, C., Bittman, R., Jacobs, W. R., & Blanchard, J. S. (1995) · Biochemistry · doi:10.1021/bi00026a004 · Cited by 373
Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis
Takayama, K., & Kilburn, J. O. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1493 · Cited by 369
Claiborne, A., & Fridovich, I. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50722-5 · Cited by 369
Finken, M., Kirschner, P., Meier, A., Wrede, A., & Böttger, E. C. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01253.x · Cited by 360
Goodwin, A., Kersulyte, D., Sisson, G., Veldhuyzen van Zanten, S. J. O., Berg, D. E., & Hoffman, P. S. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00806.x · Cited by 353
GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis
Ling, D. I., Zwerling, A. A., & Pai, M. (2008) · European Respiratory Journal · doi:10.1183/09031936.00061808 · Cited by 340
Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis
DeBarber, A. E., Mdluli, K., Bosman, M., Bekker, L.-G., & Barry, C. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9677 · Cited by 338
Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis
Chan, E. D., Laurel, V., Strand, M. J., Chan, J. F., Huynh, M.-L. N., Goble, M., & Iseman, M. D. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200308-1159oc · Cited by 336
Ramaswamy, S. V., Reich, R., Dou, S.-J., Jasperse, L., Pan, X., Wanger, A., Quitugua, T., & Graviss, E. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1241-1250.2003 · Cited by 336
Antibiotic treatment for pelvic infection.
Satta, G., & Fontana, R. (1987) · PubMed · Cited by 336
Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations
Sreevatsan, S., Stockbauer, K. E., Pan, X., Kreiswirth, B. N., Moghazeh, S. L., Jacobs, W. R., Telenti, A., & Musser, J. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1677 · Cited by 335
Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis
Scorpio, A., Lindholm-Levy, P., Heifets, L., Gilman, R., Siddiqi, S., Cynamon, M., & Zhang, Y. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.540 · Cited by 333
Heym, B., Alzari, P. M., Honore, N., & Cole, S. T. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02238.x · Cited by 330
Self-citationRawat, R., Whitty, A., & Tonge, P. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235848100 · Cited by 330
Cohen, S. P., Levy, S. B., Foulds, J., & Rosner, J. L. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.24.7856-7862.1993 · Cited by 329
Telenti, A., Honoré, N., Bernasconi, C., March, J., Ortega, A., Heym, B., Takiff, H. E., & Cole, S. T. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.3.719-723.1997 · Cited by 320
Self-citationAntibiotic inhibitors of the bacterial ribosome
Weisblum, B., & Davies, J. (1968) · Bacteriological Reviews · doi:10.1128/br.32.4_pt_2.493-528.1968 · Cited by 318
Fluoroquinolones: Action and Resistance
Drlica, K., & Malik, M. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452537 · Cited by 317
Infectious multiple drug resistance.
Falkow, S. (1975) · Medical Entomology and Zoology · Cited by 316
Mechanisms of Antibiotic Resistance in Bacteria
Benveniste, R., & Davies, J. (1973) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.42.070173.002351 · Cited by 316
Permeability barrier to hydrophilic solutes in Mycobacterium chelonei
Jarlier, V, & Nikaido, H. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.3.1418-1423.1990 · Cited by 315
Introduction of foreign DNA into mycobacteria using a shuttle phasmid
Jacobs, W. R., Tuckman, M., & Bloom, B. R. (1987) · Nature · doi:10.1038/327532a0 · Cited by 314
Musser, J. M., Kapur, V., Williams, D. L., Kreiswirth, B. N., van Soolingen, D., & van Embden, J. D. A. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.1.196 · Cited by 313
Activation of the Pro-drug Ethionamide Is Regulated in Mycobacteria
Baulard, A. R., Betts, J. C., Engohang-Ndong, J., Quan, S., McAdam, R. A., Brennan, P. J., Locht, C., & Besra, G. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003744200 · Cited by 311
On the mechanism of rifampicin inhibition of RNA synthesis.
McClure, W. R., & Cech, C. L. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34269-2 · Cited by 310
Vernon, A., Burman, W., Benator, D., Khan, A., & Bozeman, L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11467-8 · Cited by 308
Okamoto, S., Tamaru, A., Nakajima, C., Nishimura, K., Tanaka, Y., Tokuyama, S., Suzuki, Y., & Ochi, K. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05585.x · Cited by 301
Biogenesis of the mycobacterial cell wall and the site of action of ethambutol
Mikusová, K., Slayden, R. A., Besra, G. S., & Brennan, P. J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2484 · Cited by 301
Takayama, K., Wang, L., & David, H. L. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.2.1.29 · Cited by 292
A Fluoroquinolone Resistance Protein from Mycobacterium tuberculosis That Mimics DNA
Hegde, S. S., Vetting, M. W., Roderick, S. L., Mitchenall, L. A., Maxwell, A., Takiff, H. E., & Blanchard, J. S. (2005) · Science · doi:10.1126/science.1110699 · Cited by 291
Mutations in Putative Mutator Genes of Mycobacterium tuberculosis Strains of the W-Beijing Family
Ebrahimi-Rad, M., Bifani, P., Martin, C., Kremer, K., Samper, S., Rauzier, J., Kreiswirth, B., Blazquez, J., Jouan, M., van Soolingen, D., et al. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0907.020803 · Cited by 288
ethA , inhA , and katG Loci of Ethionamide-Resistant Clinical Mycobacterium tuberculosis Isolates
Morlock, G. P., Metchock, B., Sikes, D., Crawford, J. T., & Cooksey, R. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3799-3805.2003 · Cited by 288
Zhang, Y., Scorpio, A., Nikaido, H., & Sun, Z. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.7.2044-2049.1999 · Cited by 285
Vilchèze, C., Morbidoni, H. R., Weisbrod, T. R., Iwamoto, H., Kuo, M., Sacchettini, J. C., & Jacobs, W. R. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.14.4059-4067.2000 · Cited by 283
Leimane, V., Riekstina, V., Holtz, T. H., Zarovska, E., Skripconoka, V., Thorpe, L. E., Laserson, K. F., & Wells, C. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17786-1 · Cited by 279
Johnsson, K., & Schultz, P. G. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00095a063 · Cited by 278
Pym, A. S., Saint-Joanis, B., & Cole, S. T. (2002) · Infection and Immunity · doi:10.1128/iai.70.9.4955-4960.2002 · Cited by 278
Self-citationMaus, C. E., Plikaytis, B. B., & Shinnick, T. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3192-3197.2005 · Cited by 273
Wolucka, B. A., McNeil, M. R., de Hoffmann, E., Chojnacki, T., & Brennan, P. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31657-5 · Cited by 272
Zimhony, O., Cox, J. S., Welch, J. T., Vilchèze, C., & Jacobs, W. R. (2000) · Nature Medicine · doi:10.1038/79558 · Cited by 270
Heym, B., Honoré, N., Schurra, C., Cole, S. T., Heym, B., Truffot-Pernot, C., Grosset, J. H., Banerjee, A., Jacobs, W. R., & van Embden, J. D. A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91338-2 · Cited by 263
Self-citationMaldhure, B. R., Munje, R. P., Zodpey, S. P., Fuladi, A. B., & Pillai, A. (1997) · Lung India · Cited by 261
McCune, R. M., & Tompsett, R. (1956) · The Journal of Experimental Medicine · doi:10.1084/jem.104.5.737 · Cited by 260
Catalases HPI and HPII in Escherichia coli are induced independently
Loewen, P. C., Switala, J., & Triggs-Raine, B. L. (1985) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(85)90782-9 · Cited by 256
Kremer, L., Douglas, J. D., Baulard, A. R., Morehouse, C., Guy, M. R., Alland, D., Dover, L. G., Lakey, J. H., Jacobs, W. R., Brennan, P. J., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000569200 · Cited by 256
Physiological Cost of Rifampin Resistance Induced In Vitro in Mycobacterium tuberculosis
Billington, O. J., McHugh, T. D., & Gillespie, S. H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1866 · Cited by 251
Telenti, A., Imboden, P., Marchesi, F., Schmidheini, T., & Bodmer, T. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2054 · Cited by 250
Mycobacterium tuberculosis Beijing Genotype Emerging in Vietnam
Anh, D. D., Borgdorff, M. W., Van, L. N., Lan, N. T. N., van Gorkom, T., Kremer, K., & van Soolingen, D. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0603.000312 · Cited by 249
Johansen, S. K., Maus, C. E., Plikaytis, B. B., & Douthwaite, S. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.044 · Cited by 244
Ramaswamy, S. V., Amin, A. G., Göksel, S., Stager, C. E., Dou, S.-J., El Sahly, H., Moghazeh, S. L., Kreiswirth, B. N., & Musser, J. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.326-336.2000 · Cited by 240
Marrakchi, H., Lanéelle, G., & Quémard, A. (2000) · Microbiology · doi:10.1099/00221287-146-2-289 · Cited by 238
Whiteway, J., Koziarz, P., Veall, J., Sandhu, N., Kumar, P., Hoecher, B., & Lambert, I. B. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.21.5529-5539.1998 · Cited by 237
Williams, D. L., Spring, L., Collins, L., Miller, L. P., Heifets, L. B., Gangadharam, P. R. J., & Gillis, T. P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1853 · Cited by 236
The Antituberculosis Drug Ethionamide Is Activated by a Flavoprotein Monooxygenase
Vannelli, T. A., Dykman, A., & Ortiz de Montellano, P. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110751200 · Cited by 232
Molecular Mechanisms of Multiple Drug Resistance in Clinical Isolates of Mycobacterium tuberculosis
Morris, S., Bai, G. H., Suffys, P., Portillo-Gomez, L., Fairchok, M., & Rouse, D. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.4.954 · Cited by 231
Yew, W. W., Chan, C. K., Chau, C. H., Tam, C. M., Leung, C. C., Wong, P. C., & Lee, J. (2000) · Chest · doi:10.1378/chest.117.3.744 · Cited by 231
Mutation of tlyA Confers Capreomycin Resistance in Mycobacterium tuberculosis
Maus, C. E., Plikaytis, B. B., & Shinnick, T. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.571-577.2005 · Cited by 228
Transposition of an antibiotic resistance element in mycobacteria
Martin, C., Timm, J., Rauzier, J., Gomez-Lus, R., Davies, J., & Gicquel, B. (1990) · Nature · doi:10.1038/345739a0 · Cited by 222
Delihas, N., & Forst, S. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5029 · Cited by 220
Directly Observed Treatment of Tuberculosis -- We Can't Afford Not to Try It
Iseman, M. D., Cohn, D. L., & Sbarbaro, J. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302253280811 · Cited by 218
Piatek, A. S., Telenti, A., Murray, M. R., El-Hajj, H., Jacobs, W. R., Kramer, F. R., & Alland, D. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.103-110.2000 · Cited by 218
Studies on the Mechanism of Action of Isoniazid and Ethionamide in the Chemotherapy of Tuberculosis
Johnsson, K., King, D. S., & Schultz, P. G. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00122a038 · Cited by 215
Heym, B., Zhang, Y., Poulet, S., Young, D., & Cole, S. T. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.13.4255-4259.1993 · Cited by 214
Self-citationMechanism of Resistance to Amikacin and Kanamycin in Mycobacterium tuberculosis
Alangaden, G. J., Kreiswirth, B. N., Aouad, A., Khetarpal, M., Igno, F. R., Moghazeh, S. L., Manavathu, E. K., & Lerner, S. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1295 · Cited by 214
Funatsu, G., & Wittmann, H. G. (1972) · Journal of Molecular Biology · doi:10.1016/0022-2836(72)90108-8 · Cited by 212
Action Mechanism of Antitubercular Isoniazid
Lei, B., Wei, C.-J., & Tu, S.-C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2520 · Cited by 208
Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria.
Sherman, D. R., Sabo, P. J., Hickey, M. J., Arain, T. M., Mahairas, G. G., Yuan, Y., Barry, C. E., & Stover, C. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6625 · Cited by 202
Takiff, H. E., Cimino, M., Musso, M. C., Weisbrod, T., Martinez, R., Delgado, M. B., Salazar, L., Bloom, B. R., & Jacobs, W. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.362 · Cited by 198
Molecular basis of rifampin resistance in Mycobacterium leprae
Honore, N., & Cole, S. T. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.414 · Cited by 198
Self-citationLi, Z., Kelley, C., Collins, F., Rouse, D., & Morris, S. (1998) · Journal of Infectious Diseases · doi:10.1086/515254 · Cited by 195
Spread of Drug-Resistant Pulmonary Tuberculosis in Estonia
Krüüner, A., Hoffner, S. E., Sillastu, H., Danilovits, M., Levina, K., Svenson, S. B., Ghebremichael, S., Koivula, T., & Källenius, G. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.9.3339-3345.2001 · Cited by 190
Marttila, H., Soini, H., Eerola, E., Vyshnevskaya, E. B., Vyshnevskiy, B. I., Otten, T. F., Vasilyef, A. V., & Viljanen, M. K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2443 · Cited by 186
Takayama, K., Schnoes, H. K., Armstrong, E. L., & Boyle, R. W. (1975) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36719-5 · Cited by 185
Zhang, Y., Garbe, T., & Young, D. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01596.x · Cited by 179
Suzuki, Y., Katsukawa, C., Tamaru, A., Abe, C., Makino, M., Mizuguchi, Y., & Taniguchi, H. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.5.1220-1225.1998 · Cited by 177
Deretic, V., Philipp, W., Dhandayuthapani, S., Mudd, M. H., Curcic, R., Garbe, T., Heym, B., Via, L. E., & Cole, S. T. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.mmi_17050889.x · Cited by 177
Self-citationCheng, S.-J., Thibert, L., Sanchez, T., Heifets, L., & Zhang, Y. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.528-532.2000 · Cited by 175
Rv2686c-Rv2687c-Rv2688c, an ABC Fluoroquinolone Efflux Pump in Mycobacterium tuberculosis
Pasca, M. R., Guglierame, P., Arcesi, F., Bellinzoni, M., De Rossi, E., & Riccardi, G. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3175-3178.2004 · Cited by 173
Role of embB in natural and acquired resistance to ethambutol in mycobacteria
Alcaide, F., Pfyffer, G. E., & Telenti, A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2270 · Cited by 172
Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis
Vilchèze, C., Av‐Gay, Y., Attarian, R., Liu, Z., Hazbón, M. H., Colangeli, R., Chen, B., Liu, W., Alland, D., Sacchettini, J. C., et al. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06365.x · Cited by 168
Novel Mutations in ndh in Isoniazid-Resistant Mycobacterium tuberculosis Isolates
Lee, A. S. G., Teo, A. S. M., & Wong, S.-Y. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2157-2159.2001 · Cited by 168
Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis
Wilson, T. M., de Lisle, G. W., & Collins, D. M. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02276.x · Cited by 166
Jin, D. J., & Gross, C. A. (1989) · Journal of Bacteriology · doi:10.1128/jb.171.9.5229-5231.1989 · Cited by 165
The effects of salicylate on bacteria
Price, C. T. D., Lee, I., & Gustafson, J. E. (2000) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(00)00042-x · Cited by 165
Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis
Hirano, K., Takahashi, M., Kazumi, Y., Fukasawa, Y., & Abe, C. (1998) · Tubercle and Lung Disease · doi:10.1016/s0962-8479(98)80004-x · Cited by 163
Nair, J., Rouse, D. A., Bai, G., & Morris, S. L. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb00924.x · Cited by 163
Basso, L. A., Zheng, R., Musser, J. M., Jacobs, W. R., & Blanchard, J. S. (1998) · The Journal of Infectious Diseases · doi:10.1086/515362 · Cited by 163
Johnsson, K., Froland, W. A., & Schultz, P. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.2834 · Cited by 160
Rouse, D. A., Li, Z., Bai, G. H., & Morris, S. L. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2472 · Cited by 160
The Chemical Approach to the Control of Tuberculosis
FOX, H. H. (1952) · Science · doi:10.1126/science.116.3006.129 · Cited by 159
Gill, M. J., Simjee, S., Al-Hattawi, K., Robertson, B. D., EASMON, C. S. F., & ISON, C. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2799 · Cited by 158
Miesel, L., Weisbrod, T. R., Marcinkeviciene, J. A., Bittman, R., & Jacobs, W. R. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.9.2459-2467.1998 · Cited by 155
Kiepiela, P., Bishop, K. S., Smith, A. N., Roux, L., & York, D. F. (2000) · Tubercle and Lung Disease · doi:10.1054/tuld.1999.0231 · Cited by 153
Traore, H., Fissette, K., Bastian, I., Devleeschouwer, M. J., & Portaels, F. (2000) · PubMed · Cited by 152
Boshoff, H. I., Mizrahi, V., & Barry, C. E. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.8.2167-2172.2002 · Cited by 152
The Prodrug Activator EtaA from Mycobacterium tuberculosis Is a Baeyer-Villiger Monooxygenase
Fraaije, M. W., Kamerbeek, N. M., Heidekamp, A. J., Fortin, R., & Janssen, D. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307770200 · Cited by 152
Liu, J., Takiff, H. E., & Nikaido, H. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.13.3791-3795.1996 · Cited by 151
Drug-resistant tuberculosis: laboratory issues
Vareldzis, B., Grosset, J. H. E., Kantor, I. N., Crofton, J., Laszlo, A., Felten, M., Raviglione, M. C., & Kochi, A. (1994) · Tubercle and Lung Disease · doi:10.1016/0962-8479(94)90096-5 · Cited by 150
Hermans, P. W., van Soolingen, D., & van Embden, J. D. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.12.4157-4165.1992 · Cited by 149
Safi, H., Sayers, B., Hazbón, M. H., & Alland, D. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01486-07 · Cited by 149
Zhou, J., Dong, Y., Zhao, X., Lee, S., Amin, A. G., Ramaswamy, S. V., Domagala, J. M., Musser, J. M., & Drlica, K. (2000) · The Journal of Infectious Diseases · doi:10.1086/315708 · Cited by 148
EFFECT OF ISONICOTINIC ACID HYDRAZIDE ON DIPHOSPHOPYRIDINE NUCLEOTIDASES
Zatman, L. J., Kaplan, N. O., Colowick, S. P., & Ciotti, M. M. (1954) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)65473-0 · Cited by 147
Control Mechanisms for Fatty Acid Synthesis in Mycobacterium Smegmatis
Bloch, K. (1977) · Advances in Enzymology - and Related Areas of Molecular Biology · doi:10.1002/9780470122907.ch1 · Cited by 146
Salfinger, M., & Heifets, L. B. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.7.1002 · Cited by 146
Payton, M. A., Auty, R., Delgoda, R., Everett, M. J., & Sim, E. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.4.1343-1347.1999 · Cited by 146
MOLECULAR BIOLOGY OF THE MYCOBACTERIA
Colston, M. J., & Lamb, F. I. (1989) · Leprosy Review · doi:10.5935/0305-7518.19890011 · Cited by 146
Guillemin, I., Jarlier, V., & Cambau, E. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.2084 · Cited by 145
Molenaar, D., van der Rest, M. E., Drysch, A., & Yücel, R. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.24.6884-6891.2000 · Cited by 143
Overcoming antimicrobial resistance by targeting resistance mechanisms
Poole, K. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775514 · Cited by 142
Agerton, T., Valway, S. E., Blinkhorn, R., Shilkret, K. L., Reves, R. R., Schluter, W. W., Gore, B., Pozsik, C. J., Plikaytis, B. B., Woodley, C. L., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/520187 · Cited by 141
Lee, R. E., Jr., Mikušová, K., Brennan, P. J., & Besra, G. S. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00153a002 · Cited by 140
Nucleotide sequence of katG, encoding catalase HPI of Escherichia coli
Triggs‐Raine, B. L., Doble, B. W., Mulvey, M. R., Sorby, P. A., & Loewen, P. C. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.9.4415-4419.1988 · Cited by 139
Saint‐Joanis, B., Souchon, H., Wilming, M., Johnsson, K., Alzari, P. M., & Cole, S. T. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3380753 · Cited by 139
Self-citationFitness of antibiotic-resistant microorganisms and compensatory mutations
Böttger, E. C., Springer, B., Pletschette, M., & Sander, P. (1998) · Nature Medicine · doi:10.1038/3906 · Cited by 138
Mycobacterial FurA is a negative regulator of catalase-peroxidase gene katG
Zahrt, T. C., Song, J., Siple, J., & Deretic, V. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02321.x · Cited by 138
Bodmer, T., Zürcher, G., Imboden, P., & Telenti, A. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.2.345 · Cited by 137
Fenlon, C. H., & Cynamon, M. H. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.3.386 · Cited by 137
Heinz, U., Hegetschweiler, Κ., Acklin, P., Faller, B., Lattmann, R., & Schnebli, H. P. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990903)38:17<2588::aid-anie2588>3.0.co;2-8 · Cited by 131
Heym, B., Stavropoulos, E., Honoré, N., Domenech, P., Saint-Joanis, B., Wilson, T. M., Collins, D. M., Colston, M. J., & Cole, S. T. (1997) · Infection and Immunity · doi:10.1128/iai.65.4.1395-1401.1997 · Cited by 131
Self-citationOutcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study
Chiang, C.-Y., Enarson, D. A., Yu, M.-C., Bai, K.-J., Huang, R.-M., Hsu, C.-J., Suo, J., & Lin, T.-P. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00125705 · Cited by 131
Alland, D., Kramnik, I., Weisbrod, T. R., Otsubo, L., Cerny, R., Miller, L. P., Jacobs, W. R., & Bloom, B. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13227 · Cited by 130
Lee, A. S. G., Lim, I. H. K., Tang, L. L. H., Telenti, A., & Wong, S. Y. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.2087 · Cited by 127
Qualitative and Quantitative Drug-susceptibility Tests in Mycobacteriology
Heifets, L. B. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/137.5.1217 · Cited by 126
Cooksey, R. C., Morlock, G. P., McQueen, A., Glickman, S. E., & Crawford, J. T. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1186 · Cited by 126
Werngren, J., & Hoffner, S. E. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.4.1520-1524.2003 · Cited by 126
Hazbón, M. H., Bobadilla-del-Valle, M., Guerrero, M. I., Basil, M. V., Filliol, I., Cavatore, M., Colangeli, R., Safi, H., Billman‐Jacobe, H., Lavender, C. J., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3794-3802.2005 · Cited by 125
Rosner, J. L. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8771 · Cited by 122
Quan, S., Venter, H., & Dabbs, E. R. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2456 · Cited by 122
Cooksey, R. C., Crawford, J. T., Jacobs, W. R., & Shinnick, T. M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.6.1348 · Cited by 122
The Role of Pyrazinamide in Tuberculosis Chemotherapy
Steele, M. A., & Prez, R. M. D. (1988) · CHEST Journal · doi:10.1378/chest.94.4.845 · Cited by 120
Permeability Barrier to Rifampin in Mycobacteria
Hui, J., Gordon, N. C., & Kajioka, R. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.11.5.773 · Cited by 117
Honoré, N., Bergh, S., Chanteau, S., Doucet‐Populaire, F., Eiglmeir, K., Garnier, T., Georges, C., Launois, P., Limpaiboon, T., Newton, S. M. C., et al. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01112.x · Cited by 117
Self-citationSlayden, R. A., & Barry, C. E. (2002) · Tuberculosis · doi:10.1054/tube.2002.0333 · Cited by 115
Haas, W., Schilke, K., Brand, J., Amthor, B., Weyer, K., Fourie, P. B., Bretzel, G., Sticht-Groh, V., & Bremer, H. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1601 · Cited by 115
E. coli ribosomes with a C912 to U base change in the 16S rRNA are streptomycin resistant.
Montandon, P.-E., Wagner, R., & Stutz, E. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04703.x · Cited by 112
Mdluli, K., Sherman, D. R., Hickey, M. J., Kreiswirth, B. N., Morris, S., Stover, C. K., & Barry, C. E. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.5.1085 · Cited by 112
Bacterial Resistance to Quinolones: Mechanisms and Clinical Importance
Wolfson, J. S., & Hooper, D. C. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.supplement_5.s960 · Cited by 110
Isoniazid-Induced Transient High-Level Resistance in Mycobacterium tuberculosis
Viveiros, M., Portugal, I., Bettencourt, R., Victor, T. C., Jordaan, A. M., Leandro, C., Ordway, D. J., & Amaral, L. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2804-2810.2002 · Cited by 110
Владиславович, М. И., Otten, T., Vyshnevskiy, B. I., & Narvskaya, O. V. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.10.3810-3813.2002 · Cited by 109
Wengenack, N. L., Uhl, J. R., Amand, A. L. S., Tomlinson, A. J., Benson, L. M., Naylor, S., Kline, B. C., Cockerill, F. R., & Rusnak, F. M. (1997) · The Journal of Infectious Diseases · doi:10.1086/514096 · Cited by 108
Wilson, T., de Lisle, G. W., Marcinkeviciene, J. A., Blanchardand, J. S., & Collins, D. M. (1998) · Microbiology · doi:10.1099/00221287-144-10-2687 · Cited by 107
Molecular determinants of drug resistance in tuberculosis.
Riska, P. F., Jacobs, W. R., & Alland, D. (2000) · PubMed · Cited by 106
Becerra, M. C., Freeman, J., Bayona, J. N., Shin, S. S., Kim, J. Y., Furin, J. J., Werner, B., Sloutsky, A., Timperi, R., Wilson, M. E., et al. (2000) · PubMed · Cited by 105
RNA polymerase rifampicin resistance mutations in Escherichia coli: Sequence changes and dominance
Ovchinnikov, Y. A., MONASTYRSKAYA, G. S., Guriev, S. O., Nf, K., Sverdlov, E. D., Gragerov, A., Bass, I. A., Kiver, I. F., Moiseeva, E. P., Igumnov, V. N., et al. (1983) · Molecular and General Genetics MGG · doi:10.1007/bf00330662 · Cited by 105
Fluoroquinolone Resistance in Patients with Newly Diagnosed Tuberculosis
Ginsburg, A. S., Hooper, N. R., Parrish, N. M., Dooley, K. E., Dorman, S. E., Booth, J., Diener‐West, M., Merz, W. G., Bishai, W. R., & Sterling, T. R. (2003) · Clinical Infectious Diseases · doi:10.1086/379328 · Cited by 105
Crystal Structure and Mechanism of Catalysis of a Pyrazinamidase from Pyrococcus horikoshii
Du, X., Wang, W., Kim, R., Yakota, H., Nguyen, H., & Kim, S.-H. (2001) · Biochemistry · doi:10.1021/bi0115479 · Cited by 104
Ribosylation by mycobacterial strains as a new mechanism of rifampin inactivation
Dabbs, E. R., Yazawa, K., Mikami, Y., Miyaji, M., Morisaki, N., Iwasaki, S., & FURIHATA, K. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.4.1007 · Cited by 101
Cited by
Dheda, K., Gumbo, T., Maartens, G., Dooley, K. E., McNerney, R., Murray, M., Furin, J., Nardell, E. A., London, L., Lessem, E., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30079-6 · Cited by 684
Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis
Rozwarski, D. A., Grant, G. A., Barton, D. H. R., Jacobs, W. R., & Sacchettini, J. C. (1998) · Science · doi:10.1126/science.279.5347.98 · Cited by 682
Brown-Elliott, B. A., Nash, K. A., & Wallace, R. J. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05030-11 · Cited by 541
Almeida Da Silva, P. E., & Palomino, J. C. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr173 · Cited by 532
Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis
Shi, W., Zhang, X., Jiang, X., Yuan, H., Lee, J. S., Barry, C. E., Wang, H., Zhang, W., & Zhang, Y. (2011) · Science · doi:10.1126/science.1208813 · Cited by 514
Metadata
- Authors
- Heym, B., Philipp, W., & Cole, S. T.
- Venue
- Current Topics in Microbiology and Immunology
- Publisher
- Springer Berlin Heidelberg
- Published
- 1996
- Volume
- 215
- Pages
- 49-69
- ISSN
- 0070-217X (ISSN-L)
- OpenAlex
- W1543200780
- Cited by
- 379
- References
- 269
- FWCI
- 1.68
- Type
- book chapter
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.